Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
Research ArticleClinical Investigation

Widespread Decrease of Type 1 Cannabinoid Receptor Availability in Huntington Disease In Vivo

Koen Van Laere, Cindy Casteels, Isabel Dhollander, Karolien Goffin, Igor Grachev, Guy Bormans and Wim Vandenberghe
Journal of Nuclear Medicine September 2010, 51 (9) 1413-1417; DOI: https://doi.org/10.2967/jnumed.110.077156
Koen Van Laere
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Cindy Casteels
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Isabel Dhollander
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Karolien Goffin
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Igor Grachev
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Guy Bormans
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Wim Vandenberghe
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Supplemental
  • Info & Metrics
  • PDF
Loading

Article Information

vol. 51 no. 9 1413-1417
DOI 
https://doi.org/10.2967/jnumed.110.077156
PubMed 
20720046

Published By 
Society of Nuclear Medicine
Print ISSN 
0161-5505
Online ISSN 
2159-662X
History 
  • Received for publication March 11, 2010
  • Accepted for publication May 3, 2010
  • Published online September 1, 2010.

Article Versions

  • previous version (August 18, 2010 - 09:29).
  • previous version (August 19, 2010 - 14:01).
  • You are viewing the most recent version of this article.
Copyright & Usage 
© 2010 by Society of Nuclear Medicine

Author Information

  1. Koen Van Laere1,
  2. Cindy Casteels1,
  3. Isabel Dhollander2,
  4. Karolien Goffin1,
  5. Igor Grachev3,
  6. Guy Bormans4 and
  7. Wim Vandenberghe2
  1. 1Division of Nuclear Medicine, Leuven University Hospital and Katholieke Universiteit Leuven, Leuven, Belgium
  2. 2Department of Neurology, Leuven University Hospital and Katholieke Universiteit Leuven, Leuven, Belgium
  3. 3Merck & Co., Inc., Imaging Center, West Point, Pennsylvania
  4. 4Laboratory of Radiopharmaceutical Chemistry, Katholieke Universiteit Leuven, Leuven, Belgium
  1. For correspondence or reprints contact: Koen Van Laere, Division of Nuclear Medicine, Leuven University Hospital, Herestraat 49, 3000 Leuven, Belgium. E-mail: koen.vanlaere{at}uzleuven.be
View Full Text

Statistics from Altmetric.com

Cited By...

  • 85 Citations
  • 104 Citations
  • Google Scholar

This article has been cited by the following articles in journals that are participating in Crossref Cited-by Linking.

  • Multiple Functions of Endocannabinoid Signaling in the Brain
    István Katona, Tamás F. Freund
    Annual Review of Neuroscience 2012 35 1
  • Clinical Endocannabinoid Deficiency Reconsidered: Current Research Supports the Theory in Migraine, Fibromyalgia, Irritable Bowel, and Other Treatment-Resistant Syndromes
    Ethan B. Russo
    Cannabis and Cannabinoid Research 2016 1 1
  • [18F]MK‐9470 PET measurement of cannabinoid CB1 receptor availability in chronic cannabis users
    Jenny Ceccarini, Rebecca Kuepper, Dieter Kemels, Jim van Os, Cécile Henquet, Koen Van Laere
    Addiction Biology 2015 20 2
  • Care and Feeding of the Endocannabinoid System: A Systematic Review of Potential Clinical Interventions that Upregulate the Endocannabinoid System
    John M. McPartland, Geoffrey W. Guy, Vincenzo Di Marzo, Andrej A. Romanovsky
    PLoS ONE 2014 9 3
  • Corticostriatal synaptic adaptations in Huntington's disease
    Joshua L Plotkin, D James Surmeier
    Current Opinion in Neurobiology 2015 33
  • CB2 Receptor in Microglia: The Guardian of Self-Control
    Joanna Agnieszka Komorowska-Müller, Anne-Caroline Schmöle
    International Journal of Molecular Sciences 2020 22 1
  • Alterations in synaptic function and plasticity in Huntington disease
    Amy I. Smith‐Dijak, Marja D. Sepers, Lynn A. Raymond
    Journal of Neurochemistry 2019 150 4
  • A double-blind, randomized, cross-over, placebo-controlled, pilot trial with Sativex in Huntington’s disease
    Jose Luis López-Sendón Moreno, Juan García Caldentey, Patricia Trigo Cubillo, Carolina Ruiz Romero, Guillermo García Ribas, M. A. Alonso Alonso Arias, María Jesús García de Yébenes, Rosa María Tolón, Ismael Galve-Roperh, Onintza Sagredo, Sara Valdeolivas, Eva Resel, Silvia Ortega-Gutierrez, María Laura García-Bermejo, Javier Fernández Ruiz, Manuel Guzmán, Justo García de Yébenes Prous
    Journal of Neurology 2016 263 7
  • Mechanisms of synaptic dysfunction and excitotoxicity in Huntington's disease
    Marja D. Sepers, Lynn A. Raymond
    Drug Discovery Today 2014 19 7
  • Cannabinoid Receptors: An Update on Cell Signaling, Pathophysiological Roles and Therapeutic Opportunities in Neurological, Cardiovascular, and Inflammatory Diseases
    Dhanush Haspula, Michelle A. Clark
    International Journal of Molecular Sciences 2020 21 20

Article usage

Article usage: August 2010 to April 2025

AbstractFullPdf
Aug 201051035
Sep 20102563777
Oct 2010332326
Nov 2010392230
Dec 201027710
Jan 2011301723
Feb 2011271314
Mar 2011162324
Apr 2011172921
May 2011193329
Jun 2011311012
Jul 2011241311
Aug 201145626
Sep 2011333731
Oct 2011423230
Nov 2011384515
Dec 201138178
Jan 201221246
Feb 2012292218
Mar 2012392522
Apr 2012463514
May 201226249
Jun 2012293319
Jul 2012383721
Aug 2012292117
Sep 201222148
Oct 2012161715
Nov 2012292515
Dec 201223147
Jan 2013351912
Feb 2013282423
Mar 2013141512
Apr 2013151211
May 201326198
Jun 201322187
Jul 20131587
Aug 201313228
Sep 2013746
Oct 201315159
Nov 201362210
Dec 2013171825
Jan 2014103518
Feb 2014182426
Mar 2014162918
Apr 2014161820
May 2014111615
Jun 2014141720
Jul 2014121611
Aug 2014945
Sep 2014201113
Oct 2014373011
Nov 201418234
Dec 201418125
Jan 201511148
Feb 2015141810
Mar 201536179
Apr 2015986
May 20159112
Jun 201516148
Jul 201571811
Aug 2015660
Sep 201518252
Oct 201516138
Nov 2015291112
Dec 2015241710
Jan 201630169
Feb 2016171010
Mar 201635622
Apr 20166109
May 201613715
Jun 201619117
Jul 20165138
Aug 201681515
Sep 2016673
Oct 2016101511
Nov 20162198
Dec 20165152
Jan 20171497
Feb 20171282
Mar 201719179
Apr 201710911
May 20171984
Jun 20171767
Jul 20178170
Aug 201718116
Sep 20179122
Oct 201716197
Nov 201712153
Dec 2017894
Jan 2018787
Feb 201814115
Mar 201812119
Apr 201810944
May 20185116
Jun 20186213
Jul 20184114
Aug 2018860
Sep 20186183
Oct 201811272
Nov 201813277
Dec 201810271
Jan 20194293
Feb 20194295
Mar 201973312
Apr 2019113112
May 201961210
Jun 2019131320
Jul 2019112213
Aug 201914337
Sep 2019462
Oct 2019201110
Nov 20191568
Dec 2019526
Jan 202014167
Feb 20201394
Mar 202019125
Apr 2020496
May 20201146
Jun 2020887
Jul 20205104
Aug 2020686
Sep 20201443
Oct 2020141015
Nov 20201349
Dec 2020977
Jan 2021166
Feb 202131913
Mar 202113016
Apr 202121911
May 20214244
Jun 20213153
Jul 202182013
Aug 202151114
Sep 2021173
Oct 2021112529
Nov 202192727
Dec 202142411
Jan 202223413
Feb 202222411
Mar 202201811
Apr 20222207
May 202232017
Jun 202211216
Jul 20222205
Aug 202221915
Sep 202232318
Oct 202212817
Nov 202212211
Dec 202222211
Jan 202352815
Feb 20231134
Mar 202384216
Apr 202351842
May 202311910
Jun 20232118
Jul 20233186
Aug 202321413
Sep 20235376
Oct 20232947
Nov 2023118330
Dec 20232211
Jan 20248288
Feb 20241296
Mar 202402646
Apr 202478519
May 202432111
Jun 20242177
Jul 202482318
Aug 202433424
Sep 202423015
Oct 202444121
Nov 20240214
Dec 202444216
Jan 202502910
Feb 202515212
Mar 2025217823
Apr 2025928826
PreviousNext
Back to top

In this issue

Journal of Nuclear Medicine: 51 (9)
Journal of Nuclear Medicine
Vol. 51, Issue 9
September 1, 2010
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Widespread Decrease of Type 1 Cannabinoid Receptor Availability in Huntington Disease In Vivo
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
Widespread Decrease of Type 1 Cannabinoid Receptor Availability in Huntington Disease In Vivo
Koen Van Laere, Cindy Casteels, Isabel Dhollander, Karolien Goffin, Igor Grachev, Guy Bormans, Wim Vandenberghe
Journal of Nuclear Medicine Sep 2010, 51 (9) 1413-1417; DOI: 10.2967/jnumed.110.077156

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Widespread Decrease of Type 1 Cannabinoid Receptor Availability in Huntington Disease In Vivo
Koen Van Laere, Cindy Casteels, Isabel Dhollander, Karolien Goffin, Igor Grachev, Guy Bormans, Wim Vandenberghe
Journal of Nuclear Medicine Sep 2010, 51 (9) 1413-1417; DOI: 10.2967/jnumed.110.077156
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
    • Abstract
    • MATERIALS AND METHODS
    • RESULTS
    • DISCUSSION
    • CONCLUSION
    • Acknowledgments
    • REFERENCES
  • Figures & Data
  • Supplemental
  • Info & Metrics
  • PDF

Related Articles

  • This Month in JNM
  • PubMed
  • Google Scholar

Cited By...

  • Effect of chronic upregulation of endocannabinoid signaling in vivo with JZL184 on striatal synaptic plasticity and motor learning in YAC128 Huntington disease mice
  • Cannabinoid Receptor 1 Is Required for Neurodevelopment of Striosome-Dendron Bouquets
  • Cannabinoid receptor 1 is required for neurodevelopment of striosome-dendron bouquets
  • Synaptic Damage and Its Clinical Correlates in People With Early Huntington Disease: A PET Study
  • Behavioral Symptoms in Premanifest Huntington Disease Correlate with Reduced Frontal CB1R Levels
  • Striatal molecular alterations in HD gene carriers: a systematic review and meta-analysis of PET studies
  • Biased Type 1 Cannabinoid Receptor Signaling Influences Neuronal Viability in a Cell Culture Model of Huntington Disease
  • Changes in Cerebral CB1 Receptor Availability after Acute and Chronic Alcohol Abuse and Monitored Abstinence
  • Google Scholar

More in this TOC Section

  • 177Lu-PSMA-617 Consolidation Therapy After Docetaxel in Patients with Synchronous High-Volume Metastatic Hormone-Sensitive Prostate Cancer: A Randomized, Phase 2 Trial
  • Transarterial Radioembolization in the TACOME Trial: Dosimetric Analysis and Clinical Features in Predicting Response and Overall Survival
  • Retreatment of Metastatic Castration-Resistant Prostate Cancer Patients with 223Ra Therapy in Daily Practice
Show more Clinical Investigation

Similar Articles

SNMMI

© 2025 SNMMI

Powered by HighWire